Block Journal
No Result
View All Result
  • Login
en English
nl Nederlandsen Englishfr Françaisde Deutschit Italianopt Portuguêsru Русскийes Españolth ไทยzh-CN 简体中文hi हिन्दीja 日本語
  • Home
  • News
  • Crypto
  • Markets
  • Investing
  • Glossary
  • Videos
  • Charts
    • Crypto
    • Forex
    • Stocks
    • Commodities
  • Magazine
Magazine
Newsletter
  • Trending Now
  • Bitcoin
  • Altcoin
  • Ethereum
  • Analysis
  • Blockchain
  • Metaverse
  • NFT
  • DeFi
  • Web3
  • GameFi
  • ICO
  • Legal
  • Security
Block Journal
  • Home
  • News
  • Crypto
  • Markets
  • Investing
  • Glossary
  • Videos
  • Charts
    • Crypto
    • Forex
    • Stocks
    • Commodities
  • Magazine
en English
nl Nederlandsen Englishfr Françaisde Deutschit Italianopt Portuguêsru Русскийes Españolth ไทยzh-CN 简体中文hi हिन्दीja 日本語
No Result
View All Result
Block Journal
No Result
View All Result
  • News
  • Crypto
  • Markets
  • Investing
  • Videos
  • Charts
Home Markets Stocks

Pfizer, Moderna hit with new Alnylam patent lawsuits over COVID-19 vaccines

News Room by News Room
May 27, 2023
in Stocks
Reading Time: 2 mins read
0 0
A A
0

By Blake Brittain

(Reuters) – Biotech company Alnylam Pharmaceuticals Inc filed new lawsuits on Friday against Pfizer Inc (NYSE:) and Moderna (NASDAQ:) Inc in Delaware federal court, again claiming that the companies’ COVID-19 vaccines infringe its patents.

The new lawsuits mark the third time Alnylam has sued Pfizer and Moderna in Delaware for allegedly violating its patent rights in lipid nanoparticle (LNP) technology, which the vaccines use to deliver genetic material into the body.

Alnylam is again seeking an unspecified share of royalties from the companies’ vaccine sales. Pfizer earned $37.8 billion from sales of its COVID-19 vaccine Comirnaty last year, while Moderna made $18.4 billion from its vaccine Spikevax.

Representatives for Alnylam, Moderna and Pfizer did not immediately respond to requests for comment on the new lawsuits. Moderna and Pfizer have denied the allegations in the earlier cases and argued that Alnylam’s patents are invalid.

Cambridge, Massachusetts-based Alnylam first sued Moderna and Pfizer last March. It filed another pair of complaints last July over an additional LNP patent, which were later consolidated with its earlier lawsuits.

The lawsuits filed Friday include four new infringement claims against Pfizer and three against Moderna.

The complaints are part of a wave of patent lawsuits filed by biotech companies over COVID-19 vaccines, including a case brought by Moderna against Pfizer last year in Massachusetts.

Alnylam told the Delaware court that it pioneered LNP technology “essential” to the mRNA-based vaccines more than a decade ago. It also said it gave Moderna confidential information about the technology in 2014 during discussions about a potential collaboration.

The cases are Alnylam Pharmaceuticals Inc v. Moderna Inc, U.S. District Court for the District of Delaware, No. 1:23-cv-00580 and Alnylam Pharmaceuticals Inc v. Pfizer Inc, U.S. District Court for the District of Delaware, No. 1:23-cv-00578.

For Alnylam: William Gaede, Sarah Columbia, Sarah Fischer, Ian Brooks and Bhanu Sadasivan of McDermott Will & Emery

For Moderna and Pfizer: attorney information not available

Read more:

Alnylam files patent infringement lawsuits against Pfizer, Moderna

Pfizer, Moderna COVID-19 vaccines infringe new Alnylam patent, lawsuits say

Pfizer says COVID-19 vaccine lawsuit is based on bogus patent

Read the full article here

ShareTweetSharePinShareShareSend

Related News

US lawmakers met Fed, FDIC to discuss Silicon Valley Bank’s collapse – Coindesk
Stocks

PwC Australia puts nine partners on leave, overhauls board amid tax leak scandal

May 29, 2023
Toyota to launch 10 new battery EV models by 2026
Stocks

ISS backs Toyota shareholder proposal on climate disclosure

May 29, 2023
This week in tech: The Nvidia-led surge
Stocks

This week in tech: The Nvidia-led surge

May 29, 2023
U.S. opens safety probe into Tesla that struck student in North Carolina
Stocks

Ford’s huge deal with Tesla: EV hits this week

May 29, 2023
TikTok mulls splitting from ByteDance if proposal with U.S. fails – Bloomberg News
Stocks

US Representative Chip Roy says ‘we’re going to try’ to stop debt ceiling deal

May 28, 2023
China signals wait-and-see stance on big jet orders
Stocks

Boeing looks to sell at least 150 737 Max jets to Riyadh Air – Bloomberg News

May 28, 2023
Texas Senate to deliberate on impeached AG Ken Paxton
Stocks

Texas Senate to deliberate on impeached AG Ken Paxton

May 28, 2023
State actor involvement in Nord Stream pipeline attacks is ‘main scenario’, says Swedish investigator
Stocks

U.S. FDA approves Lexicon Pharma’s drug for heart failure

May 28, 2023
WestJet, pilots in tentative deal for 24% hourly raise over 4 years, document shows
Stocks

WestJet, pilots in tentative deal for 24% hourly raise over 4 years, document shows

May 28, 2023

Discussion about this post

Latest News

US debt deal passage in Congress would trim 2024 GDP by just 0.1% – Goldman Sachs

US debt deal passage in Congress would trim 2024 GDP by just 0.1% – Goldman Sachs

May 29, 2023
TikTokker mortgages house for $500K to buy XRP, now losing money

TikTokker mortgages house for $500K to buy XRP, now losing money

May 29, 2023
Mask Network (MASK) price is up 10% today: Here’s why

Mask Network (MASK) price is up 10% today: Here’s why

May 29, 2023
Indian Crypto Exchanges Are in Survival Mode, Trying to Extend Their Runways

Indian Crypto Exchanges Are in Survival Mode, Trying to Extend Their Runways

May 29, 2023
Asian stocks rise on US debt ceiling deal

Asian stocks rise on US debt ceiling deal

May 29, 2023
ADVERTISEMENT

Popular

  • EU states back ban on destruction of unsold clothing

    EU states back ban on destruction of unsold clothing

    0 shares
    Share 0 Tweet 0
  • Why the PBA Is Putting Bowling Awards On-Chain With Avalanche NFTs

    0 shares
    Share 0 Tweet 0
  • Bitcoin Climbs Past $27.4K but Remains in Holding Pattern as Investors Continue Their Debt Limit Vigil

    0 shares
    Share 0 Tweet 0
  • Crude Oil Futures: Further upside in the pipeline near term

    0 shares
    Share 0 Tweet 0
  • Blockchain Essential for Democratizing AI, Says SingularityNET COO 

    0 shares
    Share 0 Tweet 0
Block Journal

Block Journal is the world’s leading source in blockchain news and updates. Follow us to stay up-to-date with all you need to know in web3.

LEARN MORE »

Recent Posts

  • US debt deal passage in Congress would trim 2024 GDP by just 0.1% – Goldman Sachs
  • PwC Australia puts nine partners on leave, overhauls board amid tax leak scandal
  • TikTokker mortgages house for $500K to buy XRP, now losing money

Trending Topics

Altcoin Analysis Bitcoin Blockchain Commodities Crypto DeFi Ethereum Forex Futures GameFi ICO Investing Legal Markets Metaverse News NFT Security Stocks Uncategorized Videos Web3

Get Informed

The most important crypto and finance news and events of the day

Be the first to know latest important news & events directly to your inbox.

By signing up, I agree to our TOS and Privacy Policy.

  • About
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact

Copyright © 2023 Block Journal - Created by Sawah Solutions.

No Result
View All Result
  • Home
  • News
  • Crypto
  • Markets
  • Investing
  • Glossary
  • Videos
  • Charts
    • Crypto
    • Forex
    • Stocks
    • Commodities
  • Magazine

Copyright © 2023 Block Journal - Created by Sawah Solutions.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.